发明名称 ROLE OF IFNG METHYLATION IN INFLAMMATORY BOWEL DISEASE
摘要 The invention relates to method of diagnosing susceptibility to inflammatory bowel disease (IBD) in an individual by obtaining a sample from the individual, assaying the sample to determine the presence or absence of one or more risk genetic variants and/or an increase in IFNG DNA methylation. In one embodiment, the present invention provides a method of diagnosing susceptibility to inflammatory bowel disease (IBD) in an individual by obtaining a sample from the individual, assaying the sample to determine the presence or absence of one or more risk genetic variants and/or an increase in IFNG DNA methylation relative to a normal subject, and diagnosing susceptibility to inflammatory bowel disease based on the presence of one or more risk genetic variants and/or an increase in IFNG DNA methylation relative to a normal subject. In another embodiment, the IBD is ulcerative colitis.
申请公布号 EP2689034(B1) 申请公布日期 2016.03.23
申请号 EP20120764214 申请日期 2012.03.26
申请人 CEDARS-SINAI MEDICAL CENTER 发明人 GONSKY, REBECCA;DEEM, RICHARD;TARGAN, STEPHAN R.
分类号 C12Q1/68;C07H21/04;G01N33/50 主分类号 C12Q1/68
代理机构 代理人
主权项
地址